|
compound organ
|
UBERON_0003103 |
[Anatomical structure that has as its parts two or more multi-tissue structures of at least two different types and which through specific morphogenetic processes forms a single distinct structural unit demarcated by bona fide boundaries from other distinct anatomical structures of different types.] |
|
nose
|
UBERON_0000004 |
[The olfactory organ of vertebrates, consisting of nares, olfactory epithelia and the structures and skeletal framework of the nasal cavity.] |
|
structure with developmental contribution from neural crest
|
UBERON_0010314 |
[An anatomical structure that has some part that develops from the neural crest.] |
|
ectoderm-derived structure
|
UBERON_0004121 |
[An anatomical structure that develops (entirely or partially) from the ectoderm.] |
|
olfactory organ
|
UBERON_0002268 |
[An organ that houses olfactory neurons and is responsible for the sense of smell. Examples include the vertebrate nose and the Drosophila dorsal organ.] |
|
Prolonged prothrombin time
|
HP_0008151 |
[Increased time to coagulation in the prothrombin time test, which is a measure of the extrinsic pathway of coagulation. The results of the prothrombin time test are often expressed in terms of the International normalized ratio (INR), which is calculated as a ratio of the patient's prothrombin time (PT) to a control PT standardized for the potency of the thromboplastin reagent developed by the World Health Organization (WHO) using the formula: INR is equal to Patient PT divided by Control PT.] |
|
Abnormal prothrombin time
|
HP_0032199 |
[Any deviation from the normal amount of time to coagulation in the prothrombin time test, which is a measure of the extrinsic pathway of coagulation. The results of the prothrombin time test are often expressed in terms of the International normalized ratio (INR), which is calculated as a ratio of the patient's prothrombin time (PT) to a control PT standardized for the potency of the thromboplastin reagent developed by the World Health Organization (WHO) using the formula: INR is equal to Patient PT divided by Control PT.] |
|
virion part
|
GO_0044423 |
[Any constituent part of a virion, a complete fully infectious extracellular virus particle.] |
|
distal axon
|
GO_0150034 |
[That part of an axon close to and including the growth cone or the axon terminus.] |
|
adverse event
|
OAE_0000001 |
[a pathological bodily process that occurs after a medical intervention. An adverse event is likely caused by the medical intervention; however, such a causal association is not required to be an adverse event.] |
|
medical intervention
|
OAE_0000002 |
[medical intervention is a planned process that has the goal of diagnosing, preventing or relieving illness or injury. ] |
|
Sore Throat
|
NCIT_C50747 |
[Any kind of inflammatory process of the tonsils, pharynx, or/and larynx characterized by pain in swallowing.] |
|
Model
|
NCIT_C16866 |
[A representation of something, often idealized or modified to make it conceptually easier to understand.] |
|
information content entity
|
IAO_0000030 |
[A generically dependent continuant that is about some thing., an information content entity is an entity that is generically dependent on some artifact and stands in relation of aboutness to some entity, An information content entity is an entity that is generically dependent on some artifact and stands in relation of aboutness to some entity] |
|
anaphase-promoting complex-dependent catabolic process
|
GO_0031145 |
[The chemical reactions and pathways resulting in the breakdown of a protein or peptide by hydrolysis of its peptide bonds, initiated by the covalent attachment of ubiquitin, with ubiquitin-protein ligation catalyzed by the anaphase-promoting complex, and mediated by the proteasome.] |
|
positive regulation of intracellular protein transport
|
GO_0090316 |
[Any process that activates or increases the frequency, rate or extent of the directed movement of proteins within cells.] |
|
positive regulation of intracellular transport
|
GO_0032388 |
[Any process that activates or increases the frequency, rate or extent of the directed movement of substances within cells.] |
|
regulation of intracellular protein transport
|
GO_0033157 |
[Any process that modulates the frequency, rate or extent of the directed movement of proteins within cells.] |
|
positive regulation of protein transport
|
GO_0051222 |
[Any process that activates or increases the frequency, rate or extent of the directed movement of a protein into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.] |
|
positive regulation of cellular protein localization
|
GO_1903829 |
[Any process that activates or increases the frequency, rate or extent of cellular protein localization. Cellular protein localization is any process in which a protein is transported to, and/or maintained in, a specific location and encompasses movement within the cell, from within the cell to the cell surface, or from one location to another at the surface of a cell.] |